AT1 — Atomo Diagnostics Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro CapNeutral
- AU$12.56m
- AU$6.34m
- AU$2.54m
- 23
- 43
- 29
- 23
Annual income statement for Atomo Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.54 | 5.37 | 6.72 | 12.3 | 2.54 |
Cost of Revenue | |||||
Gross Profit | 0.096 | 3.19 | 3.42 | 4.25 | 0.667 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.18 | 9.32 | 12.8 | 18 | 12.5 |
Operating Profit | -4.64 | -3.95 | -6.1 | -5.7 | -9.94 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.06 | -9.22 | -6.02 | -5.71 | -9.96 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.06 | -9.22 | -6.02 | -5.71 | -9.96 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.06 | -9.22 | -6.02 | -5.71 | -9.96 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.06 | -9.22 | -6.02 | -5.71 | -9.96 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -0.015 | -0.01 | -0.009 | -0.015 |
Dividends per Share |